Results 131 to 140 of about 83,999 (309)
Topical latanoprost does not cause macular thickening after uncomplicated cataract surgery. [PDF]
PurposeTo explore changes in central macular thickness (CMT) after a two-month period of glaucoma therapy with topical latanoprost after uneventful phacoemulsification.MethodsForty-one eyes of 31 patients with primary open angle or pseudoexfoliative ...
Amini, Heydar+7 more
core +1 more source
ABSTRACT Background High myopia (HM) is a major risk factor for glaucoma. However, glaucomatous optic neuropathy is often undiagnosed owing to atypical structural alterations with axial elongation. Moreover, an algorithm to detect glaucoma in highly myopic eyes has not yet been reported.
Xiaohong Chen+14 more
wiley +1 more source
Диагностические возможности метода мультифокальной электроретинографии у больных сахарным диабетом с клинически значимым макулярным отеком [PDF]
Методами оптичної когерентної томографії та мультифокальної електороретинографії обстежено 14 пацієнтів (22 ока) з різними видами діабетичного макулярного набряку та 9 здорових осіб (9 очей).
Кузнецова, Т.А.+4 more
core
: Diabetic retinopathy and diabetic macular edema comprise a major source of visual disability throughout the developed world. The etiology and pathogenesis of macular edema is intricate and multifactorial, in which the hyperglycemic state in diabetes ...
K. Miller, J. Fortun
semanticscholar +1 more source
Cataract Surgery in the Small Adult Eye: A Review
ABSTRACT Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Advances in IOL power calculation, including artificial intelligence‐driven formulas, improve accuracy ...
Jonathan E. Moore+2 more
wiley +1 more source
BackgroundDiabetic macular edema (DME) can be treated with different alternatives, among them Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) has demonstrated that may improve both central macular thickness (CMT) and best corrected visual acuity ...
V. Castro-Navarro+5 more
semanticscholar +1 more source
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang+8 more
wiley +1 more source
Hiroko Kawashima, Kenichi Mizukawa, Junichi KiryuDepartment of Ophthalmology, Kawasaki Medical School, Okayama, JapanBackground: The purpose of this retrospective chart review was to evaluate factors associated with improvement of visual acuity after a ...
Kawashima H, Mizukawa K, Kiryu J
doaj
Introduction: The Retro-IDEAL (ILUVIEN Implant for chronic DiabEtic MAcuLar edema) study is a retrospective study designed to assess real-world outcomes achieved with the ILUVIEN® (0.19 mg fluocinolone acetonide (FAc)) in patients with chronic diabetic ...
A. Augustin+15 more
semanticscholar +1 more source
ABSTRACT Background Artificial intelligence (AI) enhanced retinal screening could reduce the impact of diabetic retinopathy (DR), the leading cause of preventable blindness in Australia. This study assessed the performance and validity of a dual‐modality, deep learning system for detection of vision‐threatening diabetic retinopathy (vtDR) in a multi ...
Jason R. Daley+12 more
wiley +1 more source